FDA Off-Label Promotion Policy Is 'Daunting Challenge' For Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite industry's 'thirst' for clarity following recent First Amendment rulings, getting legislators to agree on a new regulatory regime will not be easy, Sidley Austin partner McConagha tells FDLI conference.